Menu
AZAD has a broad portfolio of FPs authorized and marketed throughout the Americas, Europe, China, MENA, CIS and ANZ
| Product | Therapeutic Indication | Status |
|---|---|---|
| Arsenic | Treatment of Acute Promyelocytic Leukemia (APL) | Manufactured in Germany |
| Amorolfine | Treatment of Nail Infection | Manufactured in Germany |
| Bendamustine |
Treatment of chronic lymphocytic leukaemia;
indolent non-Hodgkin’s lymphomas; multiple myeloma |
Manufactured in Germany |
| Brinzolamide | Treatment of Glaucoma |
Non-infringing formulation Successful comparative efficacy study completed in 2014 Manufactured in Portugal |
| Brinzolamide & Timolol | Treatment of Glaucoma |
Non-infringing formulation Successful comparative efficacy study completed in 2017 Manufactured in Portugal |
| Iron Sucrose | Treatment of Iron Deficiency |
BE-study, Biodistribution study in Animal successfully performed Manufactured in Greece |
| Latanoprost | Treatment of Glaucoma | Manufactured in Italy and Korea |
| Latanoprost & Timolol | Treatment of Glaucoma | Manufactured in Korea |
© 2019 All rights Reserved AZAD Pharma AG